HRT Financial’s Celularity CELU Stock Holding History

HRT Financial’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$33K	Buy	56,591 +43,807	+343%	+$42K	﹤0.01%	3855
2026 Q1	$17K	Buy	+12,784	New	+$16.2K	﹤0.01%	3585
2025 Q4	–	Sell	-16,062	Closed	-$33K	–	3253
2025 Q3	$33K	Buy	+16,062	New	+$45K	﹤0.01%	2645
2023 Q3	–	Sell	-14,009	Closed	-$74K	–	2453
2023 Q2	$74K	Buy	+14,009	New	+$89.7K	﹤0.01%	2001
2022 Q2	–	Sell	-16,634	Closed	-$1.45M	–	3001
2022 Q1	$1.45M	Buy	16,634 +6,297	+61%	+$377K	0.01%	807
2021 Q4	$529K	Sell	10,337 -4,147	-29%	-$265K	﹤0.01%	1709
2021 Q3	$1.02M	Buy	14,484 +7,030	+94%	+$567K	0.01%	1247
2021 Q2	$758K	Buy	7,454 +135	+2%	+$13.7K	0.01%	1339
2021 Q1	$737K	Buy	+7,319	New	+$750K	0.01%	1494

Other funds holding CELU

CVSC

C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFO

Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return

HWM

HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

HRT Financial's CELU Position: Q2 2026 in Review

HRT Financial increased its Celularity (CELU) stake by 343% in Q2 2026, buying an estimated $42K and bringing the position to 56,591 shares worth $33K. The position accounts for ﹤0.01% of the portfolio, ranked #3855.

HRT Financial first reported a position in CELU in Q1 2021 and has held it in 9 quarters since. The position peaked at $1.45M in Q1 2022. 39 funds tracked by Wall St. Rank hold CELU as of Q2 2026.

HRT Financial held 56,591 shares of Celularity worth $33K as of Q2 2026.
HRT Financial bought 43,807 Celularity shares in Q2 2026, an estimated $42K.
Celularity made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3855 holding.
HRT Financial first reported a position in Celularity in Q1 2021 and has held it in 9 quarters since.
HRT Financial's Celularity position peaked at $1.45M in Q1 2022.
39 funds tracked by Wall St. Rank held Celularity as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.